Full-Time

Grassroots Manager

Idaho

Posted on 9/18/2025

American Cancer Society Cancer Action Network

American Cancer Society Cancer Action Network

201-500 employees

Advocates cancer research funding and policy

Compensation Overview

$56k - $67k/yr

Boise, ID, USA

Remote

Remote within Idaho; field work across the state as needed.

Category
Business & Strategy (2)
,
Requirements
  • Bachelor's degree and three to five years of relevant work experience.
Responsibilities
  • Develop and implement comprehensive local and state grassroots strategies and advocacy campaigns, demonstrating volunteer constituent support for cancer-related policy initiatives.
  • Use fundamental principles of Direct-Action Organizing.
  • Support federal campaigns and congressional champion building for the organization's issues, working collaboratively to execute strategy.
  • Organize volunteers to complete federal activities in collaboration with national team.
  • Write and disseminate e-mails to volunteers, legislative alerts, issue talking points, and training curriculum for a diverse audience of volunteers.
  • Communicate strategically using messages that are tailored to the specific political environments and attuned to the rapid pace of legislative activities.
  • Plan and manage lobby days or similar events, including virtual, to drive engagement and policy wins.
  • Maintain ACS CAN web pages, Facebook page, and/or other social media accounts according to organizational guidelines and standards, coordinating where applicable.
  • Identify and develop volunteers with personal stories related to ACS CAN's policy campaigns.
  • Serve as the staff manager of the volunteer structure in the assigned geography coordinating appropriately with leadership volunteers.
  • Accountable to filling any vacancies in the structure and ensuring sufficient capacity throughout the geography.
  • Coordinate campaign activities with grassroots coalition partners, as well as with regional and national ACS CAN grassroots teams.
  • Accurately and effectively represent ACS CAN and its mission in a manner commensurate with the organization's brand.
  • Establish and maintain strategic collaborations and partnerships with other organizations, as appropriate.
  • Execute other duties as assigned.
Desired Qualifications
  • Political issue or campaign organizing experience strongly preferred.
  • Experience attracting, developing, and engaging volunteers preferred.
  • Fundraising experience a plus.
  • Experience using Salesforce, Every Action, or similar tools a plus.
  • Experience or familiarity with fundamentals of Direct-Action Organizing a plus.
American Cancer Society Cancer Action Network

American Cancer Society Cancer Action Network

View

ACS CAN is the nonprofit, nonpartisan advocacy arm of the American Cancer Society that pushes public policy to reduce cancer. It operates across federal, state, and local levels by mobilizing a nationwide grassroots network of patients, survivors, and families to advocate for policy changes. Its main focus is securing funding for cancer research and prevention, ensuring access to affordable, quality healthcare, and promoting tobacco control and healthy living. As a 501(c)(4) organization, ACS CAN can engage in lobbying and political activity, funded by donations and fundraising, with the goal of lowering cancer incidence and mortality through evidence-based public policy.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • Mississippi's Jill’s Law signed April 2026 makes it 23rd state mandating biomarker coverage.
  • Delaware Advocacy Day March 11, 2026 gains bipartisan support for SB 120.
  • New York Senate rejects Medicaid biomarker rollback March 11, 2026 preserving access.

What critics are saying

  • Patients Rising secures Mississippi HB 565, diverting donors within 6-12 months.
  • Alzheimer's Association co-hosts Delaware event, splitting volunteers and attention.
  • Biomarker laws in 23 states erode platform, causing donor fatigue in 12-24 months.

What makes American Cancer Society Cancer Action Network unique

  • ACS CAN mobilizes cancer survivors for federal, state, local lobbying since 2001.
  • As 501(c)(4) affiliate, ACS CAN lobbies unrestricted unlike parent 501(c)(3) ACS.
  • ACS CAN prioritizes NIH/NCI funding, biomarker access, tobacco control policies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Paid Vacation

401(k) Retirement Plan

Wellness Program

Professional Development Budget

Company News

American Cancer Society Cancer Action Network
Mar 11th, 2026
'Delaware Advocacy Day' Brings Patient Advocates to Dover to Discuss Affordability of Biomarker Testing

'Delaware Advocacy Day' brings patient advocates to Dover to discuss affordability of biomarker testing. Advocates connected with their lawmakers, asking them to extend biomarker testing access to Delaware patients who can benefit. March 11, 2026 Earlier today, cancer survivors, medical professionals and patient advocates from across Delaware convened in Dover at Legislative Hall as a part of 'Delaware Advocacy Day.' The main focus of Advocacy Day, which was hosted by the American Cancer Society Cancer Action Network (ACS CAN) and the Alzheimer's Association (ALZ), was for volunteers to connect directly with legislators and ask for their support of Senate Bill 120, a bipartisan proposal to improve Delawareans' access to biomarker testing. Biomarker testing blows the door wide open for present and future treatment options for diseases like cancer and Alzheimer's as well as ALS, preeclampsia, Parkinson's and many other conditions. By identifying the unique characteristics of a patient's disease, biomarker testing enables providers to tailor therapies to the individual's specific disease, crafting a treatment plan aimed at improving outcomes and quality of life. Earlier this year in his budget address, Governor Meyer identified biomarker testing access as a priority for his administration. He visited with advocates today to hear firsthand why removing barriers to this vital tool is essential to patients and the health care and equity landscape in Delaware. Advocates from both ACS CAN and ALZ are hopeful that state lawmakers join the governor in prioritizing expanded access to biomarker testing through SB 120. Among the advocates who are asking lawmakers to improve biomarker testing access was Darcy Burbage, an oncology clinical nurse specialist who helps maintain the Oncology Nursing Society Biomarker Database. She shares how biomarker testing changed the trajectory for one of her patients. "Because of biomarker testing, a patient that I cared for was able to access a targeted therapy specifically designed to treat the variant identified by testing. Within weeks, her symptoms improved and two years later, she is working, spending time with her family and continuing to receive treatment tailored to her," said Darcy. "Expanding insurance coverage of biomarker testing helps ensures more patients receive the individualized care they deserve." Lance Kilpatrick, government relations director for ACS CAN in Delaware, noted that state lawmakers were highly receptive to the advocates' points. "Ensuring that more Delawareans have access to proven biomarker testing means more patients facing cancer and other chronic diseases will have the information they need to identify the best treatments available," said Kilpatrick. "Many legislators signaled strong interest today, and we're optimistic about bipartisan support for SB 120." If Delaware passes SB 120, it will become the 23rd state to expand access to biomarker testing. Each of Delaware's neighboring states have taken this step. About ACS CAN The American Cancer Society Cancer Action Network (ACS CAN) advocates for evidence-based public policies to reduce the cancer burden for everyone. Cancer Action Network, Inc. engage its volunteers across the country to make their voices heard by policymakers at every level of government. Cancer Action Network, Inc. believe everyone should have a fair and just opportunity to prevent, detect, treat, and survive cancer. Since 2001, as the American Cancer Society's nonprofit, nonpartisan advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. Cancer Action Network, Inc. stand with its volunteers, working to make cancer a top priority for policymakers in cities, states and its nation's capital. Join the fight by visiting www.fightcancer.org. Media contacts. Casey O'Neill Sr. Regional Media Advocacy Manager Related press releases. March 11, 2026 The one-house budget proposals revealed a clear divide in the Legislature's approach to the equitable treatment of disease. The New York State Senate flatly rejected the governor's proposal to roll back Medicaid coverage criteria for biomarker testing, heeding the calls of cancer survivors, patient advocates and public health organizations, like the American Cancer Society Cancer Action Network (ACS CAN). The Assembly took a more mixed approach accepting parts of the Governor's proposed language while rejecting others. March 4, 2026 JACKSON, Miss. - The Mississippi Senate passed "Jill's Law" House Bill 565 Wednesday, paving the way for increased access to biomarker testing for Mississippians with state-regulated he February 11, 2026 JACKSON, Miss. - The Mississippi Senate passed Senate Bill 2694 Wednesday, February 11, paving the way for increased access to biomarker testing for patients across the Magnolia State.

INACTIVE